Total Funding
19
25
Total FundingGrant raised
Growth Score
-35 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
122409
Ology Bio is a biologics CDMO specializing in single use processes up to BSL-3
- Ron Cobb: Chief Scientific OfficerPast Role: Nanotherapeutics, Chief Scientific Officer
- Bärbel Eppler: SVP Regulatory and Quality
About the Company
The company was founded in 1999 as a company focused on R&D for biopharmaceuticals and medical devices (Nanotherapeutics). In 2017 the company was transformed (and renamed) as a biologics CDMO providing manufacturing up to BSL-3.
